Irving E. Vega
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Irving E. Vega has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Andrew Umstead
Department of Translational Neuroscience, College of Human Medicine, Michigan State University
7 shared publications- Jared Lamp
Integrated Mass Spectrometry Unit, Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA
5 shared publications Ahlam S. Soliman
Department of Translational Neuroscience, College of Human Medicine, Michigan State University
2 shared publications- Ahlam S. Soliman
Affiliation Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, Michigan, United States of America
2 shared publications - Bonnie L. Firestein
Rutgers University
2 shared publications - Elizabeth Ensink
Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA
2 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1833887
Investigating the role of EFhd2 protein in modulating tau pathology in a tauopathy mouse model
Accumulation of abnormally aggregated tau is the main pathological hallmark in tauopathies, including Alzheimer’s disease (AD). Increasing evidence suggests that pretangle oligomeric tau aggregates exert neurotoxicity, while neurofibrillary tangles (NFTs) may represent less toxic structures that possibly delay cellular demise. A multitude of in vitro studies have endorsed the low propensity of tau protein to aggregate without an external aggregation inducer. Hence, studying tau-interacting proteins has garnered research attention in the last decade as potential contributors to pathological tau aggregation. We identified EF-Hand Domain Family Member D2 (EFhd2) protein as a tau-associated protein in JNPL3 mouse model and postmortem tauopathies tissues. Recently, we have shown that EFhd2 interacts with tau filaments in vitro , promoting the formation of large unique aggregated structures. Based on these findings and others, we hypothesized that EFhd2 might contribute to the formation of tau aggregates in vivo . To test this hypothesis, we examined the impact of deleting the Efhd2 gene on the progressive pathological phenotype and neuropathological changes in Tau P301L -expressing mice. The results indicated only modest, sex-specific differences in lifespan associated with Efhd2 deletion in Tau P301L mice. Independent of p -values, Efhd2 deletion also showed a medium-to-large main effect in reducing cortical pSer422 and PHF1 tau levels in aged mice, consistent with attenuated late-stage tau aggregation. Moreover, Efhd2 deletion showed effect-size–based trends toward higher Alz50 staining, suggesting an increase in early pathological tau conformations. These findings indicate that Efhd2 deletion is associated with a shift in tau species toward earlier conformational states alongside reduced markers of later-stage aggregation. The observed modest effects do not establish a direct mechanistic role for EFhd2 in tau aggregation in vivo . Rather, they suggest that EFhd2 may function as a modulatory component within a broader protein network influencing tau pathology. Future studies will determine to the extent to which these effects arise from direct modulation of tau aggregation, altered cellular pathways, or interactions within the EFhd2-associated protein network.
- 12 August 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1833887
Open AccessInvestigating the role of EFhd2 protein in modulating tau pathology in a tauopathy mouse model
Accumulation of abnormally aggregated tau is the main pathological hallmark in tauopathies, including Alzheimer’s disease (AD). Increasing evidence suggests that pretangle oligomeric tau aggregates exert neurotoxicity, while neurofibrillary tangles (NFTs) may represent less toxic structures that possibly delay cellular demise. A multitude of in vitro studies have endorsed the low propensity of tau protein to aggregate without an external aggregation inducer. Hence, studying tau-interacting proteins has garnered research attention in the last decade as potential contributors to pathological tau aggregation. We identified EF-Hand Domain Family Member D2 (EFhd2) protein as a tau-associated protein in JNPL3 mouse model and postmortem tauopathies tissues. Recently, we have shown that EFhd2 interacts with tau filaments in vitro , promoting the formation of large unique aggregated structures. Based on these findings and others, we hypothesized that EFhd2 might contribute to the formation of tau aggregates in vivo . To test this hypothesis, we examined the impact of deleting the Efhd2 gene on the progressive pathological phenotype and neuropathological changes in Tau P301L -expressing mice. The results indicated only modest, sex-specific differences in lifespan associated with Efhd2 deletion in Tau P301L mice. Independent of p -values, Efhd2 deletion also showed a medium-to-large main effect in reducing cortical pSer422 and PHF1 tau levels in aged mice, consistent with attenuated late-stage tau aggregation. Moreover, Efhd2 deletion showed effect-size–based trends toward higher Alz50 staining, suggesting an increase in early pathological tau conformations. These findings indicate that Efhd2 deletion is associated with a shift in tau species toward earlier conformational states alongside reduced markers of later-stage aggregation. The observed modest effects do not establish a direct mechanistic role for EFhd2 in tau aggregation in vivo . Rather, they suggest that EFhd2 may function as a modulatory component within a broader protein network influencing tau pathology. Future studies will determine to the extent to which these effects arise from direct modulation of tau aggregation, altered cellular pathways, or interactions within the EFhd2-associated protein network.
- Open Access
- 6 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (10) , eaeb0460
Differential SP4 expression and HSP60 abundance in buccal swabs from patients with schizophrenia
Schizophrenia (SCZ) is heterogenous and polygenic, making it difficult to diagnose and treat. This is expected as diagnostic criteria are solely based on behavioral markers. There is a critical need for easy-to-collect biomarkers that aid in treatment. To identify potential biomarkers, we recruited patients with SCZ and controls. Using buccal cell lysates, we performed real-time quantitative polymerase chain reaction and identified significant differences in Sp4 mRNA between patients and controls. Targeted mass spectrometry identified increased heat shock protein 60 (HSP60) in SCZ samples. To determine the utility of Sp4 mRNA and HSP60 protein as biomarkers, we evaluated their relationship with symptom severity and aberrant cognitive processes. Correlational analyses revealed that elevated Sp4 mRNA and HSP60 protein define a subgroup of patients with SCZ who demonstrate symptomology and poor memory. These data support buccal cell Sp4 mRNA and HSP60 protein as easy-to-collect, candidate SCZ biomarkers for a subset of patients.
- 6 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (10) , eaeb0460
Open AccessDifferential SP4 expression and HSP60 abundance in buccal swabs from patients with schizophrenia
Schizophrenia (SCZ) is heterogenous and polygenic, making it difficult to diagnose and treat. This is expected as diagnostic criteria are solely based on behavioral markers. There is a critical need for easy-to-collect biomarkers that aid in treatment. To identify potential biomarkers, we recruited patients with SCZ and controls. Using buccal cell lysates, we performed real-time quantitative polymerase chain reaction and identified significant differences in Sp4 mRNA between patients and controls. Targeted mass spectrometry identified increased heat shock protein 60 (HSP60) in SCZ samples. To determine the utility of Sp4 mRNA and HSP60 protein as biomarkers, we evaluated their relationship with symptom severity and aberrant cognitive processes. Correlational analyses revealed that elevated Sp4 mRNA and HSP60 protein define a subgroup of patients with SCZ who demonstrate symptomology and poor memory. These data support buccal cell Sp4 mRNA and HSP60 protein as easy-to-collect, candidate SCZ biomarkers for a subset of patients.
- Open Access
- 11 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (28) , eads5467
Cypin regulates K63-linked polyubiquitination to shape synaptic content
An open question in neuroscience is how protein posttranslational modifications regulate synaptic site targeting. Polyubiquitination plays a role in proteasome-mediated protein turnover; however, additional functions for specific types of polyubiquitin linkages have been identified. One type of polyubiquitination, K63-polyubiquitin (K63-polyUb), has been studied for its role in signal transduction within the context of cancer, but little has been done to uncover its role regarding neuronal and synaptic function. Here, we report an emerging function for the cytosolic PSD-95 interactor, cypin, in the regulation of synaptic content by K63-polyUb during neuronal development in vitro and in adult mice in vivo. We identify cypin-promoted K63-polyUb on postsynaptic proteins and also find an important role for cypin in presynaptic function. Our work demonstrates that cypin-promoted changes to K63-polyUb can regulate synaptic content and function on both sides of the synapse, adding important insight into basic mechanisms of neuronal signaling.
- 11 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (28) , eads5467
Open AccessCypin regulates K63-linked polyubiquitination to shape synaptic content
An open question in neuroscience is how protein posttranslational modifications regulate synaptic site targeting. Polyubiquitination plays a role in proteasome-mediated protein turnover; however, additional functions for specific types of polyubiquitin linkages have been identified. One type of polyubiquitination, K63-polyubiquitin (K63-polyUb), has been studied for its role in signal transduction within the context of cancer, but little has been done to uncover its role regarding neuronal and synaptic function. Here, we report an emerging function for the cytosolic PSD-95 interactor, cypin, in the regulation of synaptic content by K63-polyUb during neuronal development in vitro and in adult mice in vivo. We identify cypin-promoted K63-polyUb on postsynaptic proteins and also find an important role for cypin in presynaptic function. Our work demonstrates that cypin-promoted changes to K63-polyUb can regulate synaptic content and function on both sides of the synapse, adding important insight into basic mechanisms of neuronal signaling.
- Open Access
- 3 May 2024
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 18, 1373410
EFhd2 co-aggregates with monomeric and filamentous tau in vitro
Tauopathies are characterized by the abnormal buildup of tau protein, with early oligomeric forms associated with neurodegeneration and the later neurofibrillary tangles possibly conferring neuroprotection. The molecular mechanisms governing the formation of these tau species are unclear. Lately, there has been an increased focus on examining the interactions between tau and other proteins, along with their influence on the aggregation of tau. Our previous work revealed EFhd2’s association with pathological tau in animal models and tauopathy brains. Herein, we examined the impact of EFhd2 on monomeric and filamentous tau in vitro. The results demonstrated that EFhd2 incubation with monomeric full length human tau (hTau40) formed amorphous aggregates, where both EFhd2 and hTau40 colocalized. Moreover, EFhd2 is entangled with arachidonic acid (ARA)-induced filamentous hTau40. Furthermore, EFhd2-induced aggregation with monomeric and filamentous hTau40 is EFhd2 concentration dependent. Using sandwich ELISA assays, we assessed the reactivity of TOC1 and Alz50—two conformation-specific tau antibodies—to EFhd2-hTau40 aggregates (in absence and presence of ARA). No TOC1 signal was detected in EFhd2 aggregates with monomeric hTau40 whereas EFhd2 aggregates with hTau in the presence of ARA showed a higher signal compared to hTau40 filaments. In contrast, EFhd2 aggregates with both monomeric and filamentous hTau40 reduced Alz50 reactivity. Taken together, our results illustrate for the first time that EFhd2, a tau-associated protein, interacts with monomeric and filamentous hTau40 to form large aggregates that are starkly different from tau oligomers and filaments. Given these findings and previous research, we hypothesize that EFhd2 may play a role in the formation of tau aggregates. Nevertheless, further in vivo studies are imperative to test this hypothesis.
- 3 May 2024
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 18, 1373410
Open AccessEFhd2 co-aggregates with monomeric and filamentous tau in vitro
Tauopathies are characterized by the abnormal buildup of tau protein, with early oligomeric forms associated with neurodegeneration and the later neurofibrillary tangles possibly conferring neuroprotection. The molecular mechanisms governing the formation of these tau species are unclear. Lately, there has been an increased focus on examining the interactions between tau and other proteins, along with their influence on the aggregation of tau. Our previous work revealed EFhd2’s association with pathological tau in animal models and tauopathy brains. Herein, we examined the impact of EFhd2 on monomeric and filamentous tau in vitro. The results demonstrated that EFhd2 incubation with monomeric full length human tau (hTau40) formed amorphous aggregates, where both EFhd2 and hTau40 colocalized. Moreover, EFhd2 is entangled with arachidonic acid (ARA)-induced filamentous hTau40. Furthermore, EFhd2-induced aggregation with monomeric and filamentous hTau40 is EFhd2 concentration dependent. Using sandwich ELISA assays, we assessed the reactivity of TOC1 and Alz50—two conformation-specific tau antibodies—to EFhd2-hTau40 aggregates (in absence and presence of ARA). No TOC1 signal was detected in EFhd2 aggregates with monomeric hTau40 whereas EFhd2 aggregates with hTau in the presence of ARA showed a higher signal compared to hTau40 filaments. In contrast, EFhd2 aggregates with both monomeric and filamentous hTau40 reduced Alz50 reactivity. Taken together, our results illustrate for the first time that EFhd2, a tau-associated protein, interacts with monomeric and filamentous hTau40 to form large aggregates that are starkly different from tau oligomers and filaments. Given these findings and previous research, we hypothesize that EFhd2 may play a role in the formation of tau aggregates. Nevertheless, further in vivo studies are imperative to test this hypothesis.
- Open Access
- 5 April 2023
- Published by Springer Nature in Journal of Cross-Cultural Gerontology
- Vol. 38 (2) , 221
Correction to: Knowledge and Attitudes of Two Latino Groups About Alzheimer Disease: A Qualitative Study
- 5 April 2023
- Published by Springer Nature in Journal of Cross-Cultural Gerontology
- Vol. 38 (2) , 221
Open AccessCorrection to: Knowledge and Attitudes of Two Latino Groups About Alzheimer Disease: A Qualitative Study
- Open Access
- 3 April 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1062385
Engaging diverse populations in aging research during the COVID-19 pandemic: Lessons learned from four National Institutes of Health funded-Centers
Background: The COVID-19 pandemic’s impact on our personal and professional lives required a rapid adaptation to the evolving health crisis and accumulating social stresses. Established measures to reduce the spread of infection and potential death had a direct effect on ongoing research that involved older adults and underrepresented racial/ethnic groups. Although important to preserve public health, these measures risk further isolation of vulnerable research participant populations and threatened established community partnerships. To address the social and research challenges evolving from the COVID-19 pandemic, four National Institutes of Health funded-Centers that engage with community members to enhance research and advance the science of aging came together to learn from each other’s efforts, approaches, and communication with community partners.Methods: Monthly meetings served as a venue to discuss the challenges of engagement with research participants and support community partners during the pandemic. The developed learning community also contributed to recognize and address research staff stress and isolation. We describe how these conversations led our Centers to address unprecedented challenges and sustain community engagement within diverse populations, especially Black/African Americans, Latinos, Middle Eastern/Arab Americans and the oldest-old.Results: The exchange of information resulted in maintaining long standing community relationships and partnerships in the face of the uncertainties generated by the pandemic. The strategies included adapting education programs to reduce risk of infection, recognizing symptoms, promoting vaccination and understanding of the effect of COVID-19 to the brain. Different strategies were used to address the effects of isolation and maintain community engagement. Although new research participant enrollment was a challenge, telephone and virtual visits allowed research participants to remain active in research. Community members participation in virtual learning events was variable, ranging from a dozen to hundreds of participants. Invitations to organize panels about newly developed topics indicated the need for information from trusted sources.Conclusion: In sum, the COVID-19 pandemic re - directed all four Centers’ commitment to community service led to developing strategies for social support, which will potentially contribute to transforming public perceptions about research and researchers.
- 3 April 2023
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1062385
Open AccessEngaging diverse populations in aging research during the COVID-19 pandemic: Lessons learned from four National Institutes of Health funded-Centers
Background: The COVID-19 pandemic’s impact on our personal and professional lives required a rapid adaptation to the evolving health crisis and accumulating social stresses. Established measures to reduce the spread of infection and potential death had a direct effect on ongoing research that involved older adults and underrepresented racial/ethnic groups. Although important to preserve public health, these measures risk further isolation of vulnerable research participant populations and threatened established community partnerships. To address the social and research challenges evolving from the COVID-19 pandemic, four National Institutes of Health funded-Centers that engage with community members to enhance research and advance the science of aging came together to learn from each other’s efforts, approaches, and communication with community partners.Methods: Monthly meetings served as a venue to discuss the challenges of engagement with research participants and support community partners during the pandemic. The developed learning community also contributed to recognize and address research staff stress and isolation. We describe how these conversations led our Centers to address unprecedented challenges and sustain community engagement within diverse populations, especially Black/African Americans, Latinos, Middle Eastern/Arab Americans and the oldest-old.Results: The exchange of information resulted in maintaining long standing community relationships and partnerships in the face of the uncertainties generated by the pandemic. The strategies included adapting education programs to reduce risk of infection, recognizing symptoms, promoting vaccination and understanding of the effect of COVID-19 to the brain. Different strategies were used to address the effects of isolation and maintain community engagement. Although new research participant enrollment was a challenge, telephone and virtual visits allowed research participants to remain active in research. Community members participation in virtual learning events was variable, ranging from a dozen to hundreds of participants. Invitations to organize panels about newly developed topics indicated the need for information from trusted sources.Conclusion: In sum, the COVID-19 pandemic re - directed all four Centers’ commitment to community service led to developing strategies for social support, which will potentially contribute to transforming public perceptions about research and researchers.
- 31 October 2022
- Published by Springer Nature
- Vol. 2551, 253-267
Liquid-Liquid Phase Separation to Study the Association of Proteins in Solution
Liquid-liquid phase separation (LLPS) is a reversible biological process that contributes to the formation of critical concentration of proteins, forming membraneless compartments that are physiologically and pathologically relevant. Several proteins have been shown to demix into liquid droplets under in vitro crowding conditions. These studies are mainly conducted in isolation using purified recombinant proteins. Recently, we used LLPS to study the association between two proteins that are co-aggregated in Alzheimer’s disease brain, tau, and EFhd2. Here, we describe how we used LLPS to determine the molecular components that contribute to the transition of these two proteins from liquid droplets to solid-like structures. Key words Liquid-liquid phase separation Tau EFhd2 Protein dynamics Aggregates
- 31 October 2022
- Published by Springer Nature
- Vol. 2551, 253-267
Liquid-Liquid Phase Separation to Study the Association of Proteins in Solution
Liquid-liquid phase separation (LLPS) is a reversible biological process that contributes to the formation of critical concentration of proteins, forming membraneless compartments that are physiologically and pathologically relevant. Several proteins have been shown to demix into liquid droplets under in vitro crowding conditions. These studies are mainly conducted in isolation using purified recombinant proteins. Recently, we used LLPS to study the association between two proteins that are co-aggregated in Alzheimer’s disease brain, tau, and EFhd2. Here, we describe how we used LLPS to determine the molecular components that contribute to the transition of these two proteins from liquid droplets to solid-like structures. Key words Liquid-liquid phase separation Tau EFhd2 Protein dynamics Aggregates
- 3 October 2021
- Published by Wiley in Journal of Neurochemistry
- Vol. 159 (6) , 992-1007
EFhd2 brain interactome reveals its association with different cellular and molecular processes
EFhd2 is a conserved calcium‐binding protein that is highly expressed in the central nervous system. We have shown that EFhd2 interacts with tau protein, a key pathological hallmark in Alzheimer's disease and related dementias. However, EFhd2’s physiological and pathological functions in the brain are still poorly understood. To gain insights into its physiological function, we identified proteins that co‐immunoprecipitated with EFhd2 from mouse forebrain and hindbrain, using tandem mass spectrometry (MS). In addition, quantitative mass spectrometry was used to detect protein abundance changes due to the deletion of the Efhd2 gene in mouse forebrain and hindbrain regions. Our data show that mouse EFhd2 is associated with cytoskeleton components, vesicle trafficking modulators, cellular stress response‐regulating proteins, and metabolic proteins. Moreover, proteins associated with the cytoskeleton, vesicular transport, calcium signaling, stress response, and metabolic pathways showed differential abundance in Efhd2(−/−) mice. This study presents, for the first time, an EFhd2 brain interactome that it is associated with different cellular and molecular processes. These findings will help prioritize further studies to investigate the mechanisms by which EFhd2 modulates these processes in physiological and pathological conditions of the nervous system. image
- 3 October 2021
- Published by Wiley in Journal of Neurochemistry
- Vol. 159 (6) , 992-1007
EFhd2 brain interactome reveals its association with different cellular and molecular processes
EFhd2 is a conserved calcium‐binding protein that is highly expressed in the central nervous system. We have shown that EFhd2 interacts with tau protein, a key pathological hallmark in Alzheimer's disease and related dementias. However, EFhd2’s physiological and pathological functions in the brain are still poorly understood. To gain insights into its physiological function, we identified proteins that co‐immunoprecipitated with EFhd2 from mouse forebrain and hindbrain, using tandem mass spectrometry (MS). In addition, quantitative mass spectrometry was used to detect protein abundance changes due to the deletion of the Efhd2 gene in mouse forebrain and hindbrain regions. Our data show that mouse EFhd2 is associated with cytoskeleton components, vesicle trafficking modulators, cellular stress response‐regulating proteins, and metabolic proteins. Moreover, proteins associated with the cytoskeleton, vesicular transport, calcium signaling, stress response, and metabolic pathways showed differential abundance in Efhd2(−/−) mice. This study presents, for the first time, an EFhd2 brain interactome that it is associated with different cellular and molecular processes. These findings will help prioritize further studies to investigate the mechanisms by which EFhd2 modulates these processes in physiological and pathological conditions of the nervous system. image
- 1 December 2020
- Published by Elsevier in Analytical Biochemistry
- Vol. 611, 113999
Validation of recombinant human protein purified from bacteria: An important step to increase scientific rigor
- 1 December 2020
- Published by Elsevier in Analytical Biochemistry
- Vol. 611, 113999
Validation of recombinant human protein purified from bacteria: An important step to increase scientific rigor
- 19 November 2020
- Published by Ethnicity and Disease Inc in Ethnicity & Disease
- Vol. 30 (Suppl) , 765-774
Partnering with Middle Eastern/Arab American and Latino Immigrant Communities to Increase Participation in Alzheimer’s Disease Research
Purpose: Recruitment and retention of US ethnic groups traditionally underrepresented in research continues to pose challenges. The Michigan Center for Contextual Factors in Alzheimer’s Disease (MCCFAD) engages with two underserved immigrant communities in Michigan – Middle Eastern/Arab Americans in metro-Detroit and Latinos in the Grand Rapids area – to recruit and retain two Participant Resource Pools (PRP).Procedures: We adapt an existing community-based participatory research (CBPR) approach to recruit Middle Eastern/Arab American and Latino adults of all ages for Alzheimer’s disease and related dementia (ADRD) research. Using American Community Survey (2014-2018) data, we compare socio-demographic characteristics of Middle Eastern/Arab Americans and Latinos living in Michigan to our PRPs. Assessment tools and community advisory board feedback identified missteps and culturally sensitive solutions.Main Findings: In the first year of MCCFAD activities, 100 Middle Eastern/ Arab Americans and 117 Latinos joined the MCCFAD PRPs. Comparisons to state-level data showed that PRP participants were on average older and more likely to be female than the Middle Eastern/Arab American and Latino populations in Michigan. Further, Middle Eastern/Arab Americans in the PRP reported higher education levels while Latinos reported lower education levels than their respective statewide populations. Community partnerships/feedback identified the importance of connecting with community leaders, attending to matters of within-group diversity, as well as language and semantics.Conclusion: Partnership with communities to develop culturally targeted and sensitive community health events can fill a significant gap in addressing ADRD health disparities by establishing sustainable relationships to increase participation in ADRD research. Ethn Dis. 2020;30(Suppl 2):765-774; doi:10.18865/ed.30.S2.765
- 19 November 2020
- Published by Ethnicity and Disease Inc in Ethnicity & Disease
- Vol. 30 (Suppl) , 765-774
Partnering with Middle Eastern/Arab American and Latino Immigrant Communities to Increase Participation in Alzheimer’s Disease Research
Purpose: Recruitment and retention of US ethnic groups traditionally underrepresented in research continues to pose challenges. The Michigan Center for Contextual Factors in Alzheimer’s Disease (MCCFAD) engages with two underserved immigrant communities in Michigan – Middle Eastern/Arab Americans in metro-Detroit and Latinos in the Grand Rapids area – to recruit and retain two Participant Resource Pools (PRP).Procedures: We adapt an existing community-based participatory research (CBPR) approach to recruit Middle Eastern/Arab American and Latino adults of all ages for Alzheimer’s disease and related dementia (ADRD) research. Using American Community Survey (2014-2018) data, we compare socio-demographic characteristics of Middle Eastern/Arab Americans and Latinos living in Michigan to our PRPs. Assessment tools and community advisory board feedback identified missteps and culturally sensitive solutions.Main Findings: In the first year of MCCFAD activities, 100 Middle Eastern/ Arab Americans and 117 Latinos joined the MCCFAD PRPs. Comparisons to state-level data showed that PRP participants were on average older and more likely to be female than the Middle Eastern/Arab American and Latino populations in Michigan. Further, Middle Eastern/Arab Americans in the PRP reported higher education levels while Latinos reported lower education levels than their respective statewide populations. Community partnerships/feedback identified the importance of connecting with community leaders, attending to matters of within-group diversity, as well as language and semantics.Conclusion: Partnership with communities to develop culturally targeted and sensitive community health events can fill a significant gap in addressing ADRD health disparities by establishing sustainable relationships to increase participation in ADRD research. Ethn Dis. 2020;30(Suppl 2):765-774; doi:10.18865/ed.30.S2.765